Detalhe da pesquisa
1.
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Cancer Immunol Immunother
; 72(11): 3839-3850, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733060
2.
Correction to: Extended duration of treatment using reducedfrequency dosing of antiPD1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Cancer Immunol Immunother
; 72(12): 4471, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979010